Efficacy and safety of cyclosporine in renal-transplant recipients.

Long-term efficacy and safety of cyclosporine in renal-transplant recipients. N Engl J Med (1994) 2.93

Which cyclosporin formulation? Lancet (1996) 3.34

Consensus statement on the live organ donor. JAMA (2000) 3.29

Analgesics and the kidney: summary and recommendations to the Scientific Advisory Board of the National Kidney Foundation from an Ad Hoc Committee of the National Kidney Foundation. Am J Kidney Dis (1996) 2.30

Synergistic effects of cyclosporine and rapamycin in a chronic nephrotoxicity model. Transplantation (1996) 2.24

The influence of dosage regimen on experimental gentamicin nephrotoxicity: dissociation of peak serum levels from renal failure. J Infect Dis (1979) 1.83

Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future. Am J Kidney Dis (2000) 1.68

Cyst decompression surgery for autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1992) 1.68

Morphine and phenytoin binding to plasma proteins in renal and hepatic failure. Clin Pharmacol Ther (1975) 1.59

Polyaspartic acid prevents experimental aminoglycoside nephrotoxicity. J Infect Dis (1989) 1.57

Renal manifestations of sarcoidosis. Arch Intern Med (1981) 1.47

Acute renal failure from ticrynafen. N Engl J Med (1979) 1.40

The influence of tobramycin dosage regimens on nephrotoxicity, ototoxicity, and antibacterial efficacy in a rat model of subcutaneous abscess. J Infect Dis (1988) 1.36

Action and toxicity of cyclosporine. Annu Rev Med (1986) 1.35

Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies. Curr Opin Crit Care (2001) 1.32

Lead nephropathy. Kidney Int (1985) 1.24

The nephropathy of the nail-patella syndrome. Clinicopathologic analysis of 11 kindred. Am J Med (1973) 1.20

Drug prescribing in renal failure: dosing guidelines for adults. Am J Kidney Dis (1983) 1.13

Vancomycin pharmacokinetics, renal handling, and nonrenal clearances in normal human subjects. Clin Pharmacol Ther (1988) 1.12

Endogenous creatinine clearance as a clinical measure of glomerular filtration rate. Br Med J (1971) 1.12

Drug-related syndromes in clinical nephrology. Ann Intern Med (1977) 1.10

Gentamicin and tobramycin nephrotoxicity. A morphologic and functional comparison in the rat. Am J Pathol (1978) 1.10

Guidelines for drug therapy in renal failure. Ann Intern Med (1977) 1.10

Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin. J Am Soc Nephrol (1995) 1.09

Nephrotoxic acute renal failure due to common drugs. Am J Physiol (1981) 1.09

Attenuation of experimental tobramycin nephrotoxicity by ticarcillin. Antimicrob Agents Chemother (1985) 1.08

Renal function 27 years after unilateral nephrectomy for related donor kidney transplantation. J Urol (1988) 1.08

Cyclosporine nephrotoxicity. Ann Intern Med (1983) 1.07

Renal cholesterol accumulation: a durable response after acute and subacute renal insults. Am J Pathol (2001) 1.05

Cyst fluid antibiotic concentrations in autosomal-dominant polycystic kidney disease. Am J Kidney Dis (1985) 1.04

Effect of sodium intake on gentamicin nephrotoxicity in the rat. Proc Soc Exp Biol Med (1976) 1.04

Reversibility of gentamicin nephrotoxicity in rats: recovery during continuous drug administration. Proc Soc Exp Biol Med (1979) 1.04

Role of splenectomy in renal transplantation. Urology (1973) 1.04

Drug dosing guidelines in patients with renal failure. West J Med (1992) 1.03

Trimethoprim-sulfamethoxazole in cyst fluid from autosomal dominant polycystic kidneys. Kidney Int (1987) 1.03

Ciprofloxacin activity in cyst fluid from polycystic kidneys. Antimicrob Agents Chemother (1988) 1.03

Djenkol bean poisoning (djenkolism): an unusual cause of acute renal failure. Am J Kidney Dis (1995) 1.02

Drug therapy in renal failure: dosing guidelines for adults. Part II: sedatives, hypnotics, and tranquilizers; cardiovascular, antihypertensive, and diuretic agents; miscellaneous agents. Ann Intern Med (1980) 1.02

Vascular mechanisms of cyclosporin-induced hypertension in the rat. J Clin Invest (1994) 1.01

Cyclosporine-induced acute renal dysfunction in the rat. Evidence of arteriolar vasoconstriction with preservation of tubular function. Transplantation (1987) 1.01

A guide to drug therapy in renal failure. JAMA (1974) 1.01

Long-term protection of polyaspartic acid in experimental gentamicin nephrotoxicity. Antimicrob Agents Chemother (1991) 1.00

Macroscopic hematuria in mesangial IgA nephropathy: correlation with glomerular crescents and renal dysfunction. Kidney Int (1983) 1.00

Ethylene glycol intoxication. Prevention of renal failure by aggressive management. JAMA (1973) 1.00

Induction of contraction in isolated rat aorta by cyclosporine. Transplantation (1987) 1.00

Postrenal transplant erythrocytosis: a review of 53 patients. Kidney Int (1983) 0.99

Chronic cyclosporine nephrotoxicity. Curr Opin Nephrol Hypertens (1998) 0.99

Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity. Kidney Int (1995) 0.98

Sex-related differences in the susceptibility of rats to gentamicin nephrotoxicity. J Infect Dis (1982) 0.97

Clinical characteristics and diagnostic considerations in acquired renal cystic disease. Kidney Int (1986) 0.97

Chronic renal disease and papillary necrosis associated with the long-term use of nonsteroidal anti-inflammatory drugs as the sole or predominant analgesic. Am J Kidney Dis (1994) 0.97

Cyclosporine-associated hypertension. Am J Med (1988) 0.97

Expression of apoptosis regulatory genes in chronic cyclosporine nephrotoxicity favors apoptosis. Kidney Int (1999) 0.97

SPARC is expressed in renal interstitial fibrosis and in renal vascular injury. Kidney Int (1996) 0.97

Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis. Kidney Int (1998) 0.96

Analgesic nephropathy--a preventable renal disease. N Engl J Med (1989) 0.96

A practical guide to drug usage in adult patients with impaired renal function. JAMA (1970) 0.96

Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506. Kidney Int (1996) 0.96

Herpes simplex type 1 hepatitis in renal transplantation. Arch Intern Med (1980) 0.95

Reduction of experimental gentamicin nephrotoxicity in rats by dietary calcium loading. Antimicrob Agents Chemother (1982) 0.95

Role of transforming growth factor-beta 1 in experimental chronic cyclosporine nephropathy. Kidney Int (1996) 0.95

Gentamicin nephrotoxicity. I. Degree and permanence of acquired insensitivity. J Lab Clin Med (1982) 0.94

Aspirin-induced depression of glomerular filtration rate in normal humans: role of sodium balance. Ann Intern Med (1981) 0.93

Angiotensin II blockade decreases TGF-beta1 and matrix proteins in cyclosporine nephropathy. Kidney Int (1997) 0.93

Dissociation of glomerular filtration rate from tubulointerstitial fibrosis in experimental chronic cyclosporine nephropathy: role of sodium intake. J Am Soc Nephrol (1993) 0.92

Guide to drug usage in adult patients with impaired renal function. A supplement. JAMA (1973) 0.92

Alterations in organic ion transport induced by gentamicin nephrotoxicity in the rat. J Lab Clin Med (1980) 0.92

Transient diabetes insipidus complicating systemic fat embolization. J Trauma (1972) 0.91

Comparative nephrotoxicities of high-dose netilmicin and tobramycin in rats. Antimicrob Agents Chemother (1980) 0.91

Focal segmental glomerulosclerosis: a need for caution in live-related renal transplantation. Am J Kidney Dis (1999) 0.91

Renal transport of organic acids and bases in aminoglycoside nephrotoxicity. Antimicrob Agents Chemother (1979) 0.91

Partial lipodystrophy, C3 nephritic factor and clinically inapparent mesangiocapillary glomerulonephritis. Am J Med (1977) 0.91

Protective effects of dietary L-arginine supplementation on chronic cyclosporine nephrotoxicity. Transplantation (1997) 0.91

Drug therapy in renal failure: dosing guidelines for adults. Part I: Antimicrobial agents, analgesics. Ann Intern Med (1980) 0.90

Mechanism of fibrosis in experimental tacrolimus nephrotoxicity. Transplantation (1997) 0.90

Myeloid bodies in the renal tubules of humans: relationship to gentamicin therapy. Clin Nephrol (1978) 0.89

Urinary tract infections in patients with severe renal disease. Treatment with ampicillin and trimethoprim-sulfamethoxazole. JAMA (1976) 0.89

Effect of nitric oxide modulation on TGF-beta1 and matrix proteins in chronic cyclosporine nephrotoxicity. Kidney Int (2000) 0.89

Effect of basis amino acids and aminoglycosides on 3H-gentamicin uptake in cortical slices of rat and human kidney. J Lab Clin Med (1982) 0.89

Reduction of cyst volume for symptomatic management of autosomal dominant polycystic kidney disease. J Urol (1987) 0.88

Factors in cardiac risk stratification of candidates for renal transplant. J Cardiovasc Risk (1999) 0.88

"Dewlap". A corticosteroid-induced episternal fatty tumor. N Engl J Med (1966) 0.88

Cyclosporine A induced arteriolopathy in a rat model of chronic cyclosporine nephropathy. Kidney Int (1995) 0.88

Drug prescribing in renal failure. Drugs (1979) 0.88

FK506 nephrotoxicity: morphologic and physiologic characterization of a rat model. Lab Invest (1995) 0.88

Achieving oral health in patients with renal failure and renal transplants. J Am Dent Assoc (1986) 0.88

Immunosuppressant-induced nephropathy: pathophysiology, incidence and management. Drug Saf (1999) 0.87

Responsibilities of primary physicians in organ donation. Ann Intern Med (1987) 0.87

Effect of sodium bicarbonate and ammonium chloride ingestion in experimental gentamicin nephrotoxicity in rats. Res Commun Chem Pathol Pharmacol (1980) 0.87

Sustained depression of the resting metabolic rate after massive weight loss. Am J Clin Nutr (1989) 0.86

Response to dopamine hydrochloride in the hepatorenal syndrome. Arch Intern Med (1975) 0.86

Parathyroid function in persistent hyperparathyroidism: relationship to gland size. Kidney Int (1982) 0.86

Renal transplantation across the ABO barrier using A2 kidneys. Transplantation (1999) 0.86

Chronic gentamicin nephrotoxicity. Continued tubular injury with preserved glomerular filtration function. Am J Pathol (1986) 0.86

Letter: Renal vein thrombosis in nephrotic syndrome. Ann Intern Med (1975) 0.86

Increasing dietary calcium moderates experimental gentamicin nephrotoxicity. J Lab Clin Med (1984) 0.86

Pharmacology of immunosuppressive drugs. Drugs Today (Barc) (1998) 0.86

Renal tubular acidosis. Arch Intern Med (1968) 0.86

Efficacy and safety of metolazone in renal failure and the nephrotic syndrome. J Clin Pharmacol (1973) 0.86

Effectiveness of a jet injection system in administering morphine and heparin to healthy adults. Am J Crit Care (1996) 0.86

Letter: Arthralgia after high-dose steroids. Lancet (1975) 0.85